Stockreport

Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD

Adverum Biotechnologies, Inc.  (ADVM) 
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: adverum.gcs-web.com/investor-overview
PDF - Clinical Hold until Additional CMC Information is Reviewed by FDA -- Independent DMC Review of Safety Data from First Cohort of Six Patients with No SAEs or DLTs -- Ad [Read more]